GLPwatch
Trials (2036)
Page 21 of 34.
- Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
- Extension Study for 2993-112
- Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
- A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
- Semaglutide's Weight Loss Effects in Obesity
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
- Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
- A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
- Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People
- A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms
- A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland
- Effect of Itopride on Semaglutide Gastroparesis
- GLP-1 Analogs for Neuroprotection After Cardiac Arrest
- Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers
- A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy
- Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes
- Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
- Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
- Effect Of Semaglutide In Coronary Atheroma Plaque
- A Study of LY3437943 in Participants With Impaired and Normal Liver Function
- A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
- Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
- A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants
- Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
- A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
- Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
- Efficacy of Mazdutide for Treating PCOS
- Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
- GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practice
- The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
- Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
- A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
- Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
- Closed Loop System With Pramlintide Versus Exenatide
- Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
- A Study of IBI362 in Chinese Patients With Type 2 Diabetes
- The Effect of Liraglutide on the GIT
- Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
- Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe
- The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
- Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
- LIraglutide and Beta-cell RepAir (LIBRA) Study
- Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
- The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
- Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
- Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
- A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
- Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects
- Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
- A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
- The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Multi-Site Trial of Tirzepatide for Smoking Cessation
- Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
- Medically Reproducing Bariatric Surgery